Navigation Links
VAI researchers develop tool to help study prostate cancer
Date:3/11/2010

Grand Rapids, Mich. (March 11, 2010) Van Andel Research Institute (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer. Using the model, they found that normal cells and cancer cells depend on different factors to survive, which could aid in discovering how to target cancer cells without affecting normal cells when developing treatments.

Prostate cancer is the most common form of cancer in men, with more than 192,000 new cases and more than 27,000 deaths reported in the United States in 2009 (Source: National Cancer Institute).

"This new model will serve as a valuable tool for understanding secretory prostate epithelial cells, which until now have not been available for extensive analysis," said VARI Scientific Investigator Cindy Miranti, Ph.D., whose lab published its study in a recent issue of the Journal of Cell Science.

Epithelial cells line and protect the internal and external organs and structures of the body. The prostate contains two types of epithelial cells, basal and secretory, and prostate cancers arise from abnormal cells as they are converted from basal into secretory cells in the body.

Prior to this study, scientists were able to culture basal cells, but not secretory cells. Using the model, researchers found that, unlike cancer cells, normal secretory cells are not dependent on the male sex hormone androgen for survival, but are dependent for survival on binding to each other via the protein E-cadherin.

"Prostate cancers are dependent on androgen for survival, so we were interested in whether normal secretory prostate epithelial cells also depend on androgen," said Dr. Miranti. "However, the cell culture models available didn't allow us to study secretory cells, so we generated them by reconstructing the natural conversion process from basal into secretory cells in a petri dish."

The differences in how cancer cells and normal cells control their survival can be exploited to develop therapies that preferentially target the tumor cells, but not the normal cells.

"This cell model will be extremely useful to investigators who are interested in studying the cell biology of prostate cancer as well as benign prostate hyperplasia," said Donald J. Tindall, Ph.D., Professor, Director & Vice Chair of Urologic Research at the Mayo Clinic College of Medicine. "Such studies should facilitate our understanding of the cellular mechanisms involved in progression of these diseases and may lead to new prognostic capabilities and therapeutic interventions."


'/>"/>

Contact: Joe Gavan
joe.gavan@vai.org
616-234-5390
Van Andel Research Institute
Source:Eurekalert

Related biology news :

1. Researchers examine plants ability to identify, block invading bacteria
2. Community involvement important in fight against childhood obesity, according to UTHealth researchers
3. Exercise counters negative effects of weight regain, researchers find
4. Rice researchers make graphene hybrid
5. New dinosaur rears its head; U-M researchers part of team announcing find
6. Discovery in legumes could reduce fertilizer use, aid environment: Stanford researchers
7. Researchers fishing for cancer cure discover active DHA derivatives
8. Researchers determine how ATP, molecule bearing the fuel of life, is broken down in cells
9. NOAA, NASA and Old Dominion researchers measure impacts of changing climate on ocean biology
10. Researchers issue outlook for a significant New England red tide in 2010
11. French and Spanish researchers develop a natural alternative to antibiotics in animal feed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... -- New research undertaken by Fit Small Business has ... were simply asked which office technology had they not used ... issue.  Insights on what will be key features ... and industry leaders including Penelope Trunk , Martin ... Some of these findings included; ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
(Date:1/4/2017)... Jan. 4, 2017  CES 2017 – Valencell ... technology, today announced the launch of two new ... the highly-accurate biometric sensor modules that incorporate the ... experience and expertise. The two new designs include ... for hearables, and Benchmark BW2.0, a 2-LED version ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... ... ... Oklahoma City based Sigma Blood Systems has established a relationship with Central ... product QC Manager 2.0. , Sigma Blood Systems CEO, Max Doleh, stated “We ... have decided to implement PERFEQTA and QC Manager 2.0, with PERFEQTA launching across multiple ...
(Date:1/24/2017)... PUNE, India , January 23, 2017 ... "Humanized Mouse Model Market by Type (Genetic, Cell-based (CD34, ... diseases) & End User (Pharmaceutical & Biotech Companies, CRO) ... report studies the global Humanized Mouse Model Market for ... is expected to reach USD 116.0 Million by 2021 ...
(Date:1/24/2017)... , Jan. 23, 2017  Today, the Fisher ... they have funded an important study that could lead ... the onset of Alzheimer,s disease. This groundbreaking research was ... University, led by Nobel Laureate Dr. Paul Greengard ... Alzheimer,s disease. Fisher Center scientists have linked ...
(Date:1/23/2017)... ... January 23, 2017 , ... USARAD ... announces significant growth last year adding 65 new US and international facilities to ... medical centers as well as one of US largest imaging center chains. USARAD ...
Breaking Biology Technology: